Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity

被引：3
|
作者：
Luscher, Thomas F. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Imperial Coll, Cardiol, London, England
[2] Royal Brompton Hosp, Res Educ & Dev, London, England
[3] Harefield Hosp London, London, England
[4] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[5] Zurich Heart House, EHJ Editorial Off, Hottingerst 14, CH-8032 Zurich, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 19期
关键词：
ORAL ANTICOAGULANTS; MANAGEMENT; STROKE; EVENTS;
D O I：
10.1093/eurheartj/ehz302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1477 / 1481
页数：5
相关论文
共 50 条
  • [31] The impact of age on intracranial Hemorrhage and 30-day mortality in patients with atrial fibrillation; The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Go, AS
    Chang, YC
    Jensvold, NG
    Selby, JV
    Singer, DE
    Hylek, EM
    CIRCULATION, 2003, 108 (17) : S - S
  • [32] Age-specific rates and predictors of major extracranial hemorrhage in patients with atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Go, AS
    Chang, YC
    Jensvold, NG
    Selby, JV
    Singer, DE
    Hylek, EM
    CIRCULATION, 2003, 108 (17) : 786 - 786
  • [33] Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis
    Nutescu E.A.
    Helgason C.M.
    Current Treatment Options in Cardiovascular Medicine, 2005, 7 (3) : 241 - 250
  • [34] Age and the risk of warfarin-associated hemorrhage: The anticoagulation and risk factors in atrial fibrillation study
    Fang, Margaret C.
    Go, Alan S.
    Hylek, Elaine M.
    Chang, Yuchiao
    Henault, Lori E.
    Jensvold, Nancy G.
    Singer, Daniel E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (08) : 1231 - 1236
  • [35] Effectiveness and safety of long-term anticoagulation of patients ≱90 years of age with atrial fibrillation
    Joffe, HV
    Goldhaber, SZ
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (12): : 1397 - +
  • [36] Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities
    Goldhaber, Samuel Z.
    Piazza, Gregory
    EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1515 - 1517
  • [37] Increasing age is not associated with poorer anticoagulation control in outpatients with non-valvular atrial fibrillation
    Hylek, E
    Go, A
    Chang, YC
    Phillips, K
    Selby, J
    Singer, D
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S58 - S58
  • [38] Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study
    Pappas, Matthew A.
    Vijan, Sandeep
    Rothberg, Michael B.
    Singer, Daniel E.
    PLOS ONE, 2018, 13 (07):
  • [39] CARDIOVERSION OF NONRHEUMATIC ATRIAL-FIBRILLATION - REDUCED THROMBOEMBOLIC COMPLICATIONS WITH 4 WEEKS OF PRECARDIOVERSION ANTICOAGULATION ARE RELATED TO ATRIAL THROMBUS RESOLUTION
    COLLINS, LJ
    SILVERMAN, DI
    DOUGLAS, PS
    MANNING, WJ
    CIRCULATION, 1995, 92 (02) : 160 - 163
  • [40] Half-dose direct oral anticoagulation versus warfarin for atrial fibrillation following cardiac surgery
    Hashim, Sabet W.
    Collazo, Susan
    Greco, Amanda
    Mather, Jeff F.
    McKay, Raymond G.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2024, 65 (02): : 169 - 176
12345